AHCO:NSD-AdaptHealth Corp (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 20.00

Change

0.00 (0.00)%

Market Cap

USD 1.37B

Volume

0.43M

Average Target Price

USD 19.14 (-4.29%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, supplies, and related services in the United States. The company focuses primarily on providing sleep therapy equipment, supplies, and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It services beneficiaries of Medicare, Medicaid, and commercial payors. The company is based in Plymouth Meeting, Pennsylvania.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-07-03 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

N/A

USD20.29B 10.92 36.11
PODD Insulet Corporation

N/A

USD12.57B 2,227.89 174.58
RCEL AVITA Therapeutics, Inc

N/A

USD11.48B -99,999.99 N/A
ABMD Abiomed, Inc

N/A

USD10.86B 57.49 40.81
LVGO Livongo Health, Inc

N/A

USD7.00B N/A N/A
BRKR Bruker Corporation

N/A

USD5.95B 35.89 18.96
TNDM Tandem Diabetes Care, Inc

N/A

USD5.14B N/A N/A
IART Integra LifeSciences Holdings ..

N/A

USD3.94B 157.42 25.24
WMGI Wright Medical Group N.V

N/A

USD3.82B N/A 41.61
SDC SmileDirectClub, Inc

N/A

USD2.87B N/A N/A

ETFs Containing AHCO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 82.15% 89% B+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.15% 89% B+ 91% A-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 1.37B 83% B 75% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio -99,999.99 88% B+ 98% A+
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 22.75 18% F 13% F
EV/EBITDA 47.80 24% F 11% F
Management Effectiveness  
Return on Equity -19.55% 63% D 35% F
Return on Invested Capital 7.49% 85% B 70% C-
Return on Assets 6.04% 90% A- 88% B+
Debt to Equity Ratio -2,721.30% 100% A+ 100% A+
Technical Ratios  
Short Ratio 9.04 10% F 10% F
Short Percent 7.24% 34% F 30% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector